Gut microbiome’s causal role in head and neck cancer: findings from mendelian randomization
Our study demonstrates, for the first time, the causal influence of specific gut microbiome compositions on HNC, offering significant insights for advancing clinical research and personalized treatments. The identified GMs may serve as potential biomarkers or therapeutic targets, paving the way for innovative approaches in HNC diagnosis, prevention, and therapy.
Authors
- Boxuan Han (ORCID: https://orcid.org/0000-0001-8205-9847)
- Minghong Sun
- Meng Lian (ORCID: https://orcid.org/0000-0003-2509-4958)
- Ancha Baranova (ORCID: https://orcid.org/0000-0001-6810-5982)
- Hongbao Cao (ORCID: https://orcid.org/0000-0001-6591-9518)
- Fuquan Zhang (ORCID: https://orcid.org/0000-0003-3204-8191)
Institutions
- Qingdao University (CN)
- Beijing Tongren Hospital (CN)
- George Mason University (US)
- Capital Medical University (CN)
- Nanjing Brain Hospital (CN)
- Qingdao Municipal Hospital (CN)
- Research Centre for Medical Genetics (RU)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-19
- DOI
- https://doi.org/10.3389/fonc.2024.1453202
- Citations
- 1
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- Beijing Municipal Administration of Hospitals